Companies / TriSalus Life Sciences, Inc. / Activity
Activity — TriSalus Life Sciences, Inc.
28 moves.
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | Stansky Michael P Director | Buy | Common Stock | $1000.0K | +244K +44.90% | 787,132 1.28% of shares | high |
| Feb 23, 2026 | Stansky Michael P Director | Buy | Common Stock | $480.5K | +117K +142.06% | 199,698 0.32% of shares | high |
| Feb 23, 2026 | Valle William Director | Buy | Common Stock | $125.0K | +30K | 30,487 0.05% of shares | medium |
| Feb 23, 2026 | Szela Mary T CEO | Buy | Common Stock | $125.0K | +30K +4.10% | 773,289 1.26% of shares | medium |
| Mar 17, 2026 | Szela Mary T CEO | Sell | Common Stock | $61.4K | -16K -2.07% | 752,987 1.22% of shares | low |
| Feb 23, 2026 | Gordon Gary B. Director | Buy | Common Stock | $40.0K | +10K | 9,756 0.02% of shares | low |
| Mar 11, 2026 | Szela Mary T CEO | Sell | Common Stock | $18.0K | -4K -0.56% | 768,931 1.25% of shares | low |
| Feb 23, 2026 | Patience David Executive | Buy | Common Stock | $15.0K | +4K +1.38% | 268,657 0.44% of shares | low |
| Mar 12, 2026 | Devlin Jodi Executive | Sell | Common Stock | $7.2K | -2K -1.78% | 97,637 0.16% of shares | low |
| Mar 12, 2026 | Marshak Richard Executive | Sell | Common Stock | $6.5K | -2K -1.41% | 110,816 0.18% of shares | low |
| Mar 12, 2026 | Stevens Jennifer Executive | Sell | Common Stock | $6.3K | -2K -1.23% | 124,884 0.20% of shares | low |
| Mar 12, 2026 | Cox Bryan F. Executive | Sell | Common Stock | $6.0K | -1K -0.89% | 163,994 0.27% of shares | low |
| Mar 11, 2026 | Marshak Richard Executive | Sell | Common Stock | $6.0K | -1K -1.27% | 112,405 0.18% of shares | low |
| Mar 11, 2026 | Stevens Jennifer Executive | Sell | Common Stock | $5.0K | -1K -0.94% | 126,436 0.21% of shares | low |
| Mar 11, 2026 | Devlin Jodi Executive | Sell | Common Stock | $4.8K | -1K -1.16% | 99,409 0.16% of shares | low |
| Mar 11, 2026 | Cox Bryan F. Executive | Sell | Common Stock | $4.7K | -1K -0.68% | 165,461 0.27% of shares | low |
| Mar 16, 2026 | Stevens Jennifer Executive | Sell | Common Stock | $3.2K | -774 -0.62% | 124,110 0.20% of shares | low |
| Mar 16, 2026 | Cox Bryan F. Executive | Sell | Common Stock | $2.4K | -579 -0.35% | 163,415 0.27% of shares | low |
| Mar 16, 2026 | Marshak Richard Executive | Sell | Common Stock | $1.7K | -419 -0.38% | 110,397 0.18% of shares | low |
| Mar 16, 2026 | Devlin Jodi Executive | Sell | Common Stock | $1.1K | -273 -0.28% | 97,364 0.16% of shares | low |
| May 14, 2026 | Matlin David J Director | Grant | Common Stock | $0 | +23K +1.77% | 1,323,210 2.15% of shares | low |
| May 14, 2026 | Matlin David J Director | Grant | Common Stock | $0 | +28K +2.22% | 1,300,145 2.11% of shares | low |
| Jul 31, 2025 | Matlin David J Director | Other | Common Stock | $0 | +330K +35.03% | 1,271,944 2.07% of shares | low |
| May 14, 2026 | Hicks Kerry R Director | Grant | Common Stock | $0 | +28K +5.48% | 542,790 0.88% of shares | low |
| May 14, 2026 | Matlin David J Director | Grant | Director Stock Option (right to buy) | — | +56K +86.77% | 121,403 0.20% of shares | low |
| Jul 31, 2025 | Matlin David J Director | Other | Series A Preferred Stock | — | -100K -100.00% | 0 0.00% of shares | low |
| May 14, 2026 | Hicks Kerry R Director | Grant | Director Stock Option (right to buy) | — | +56K +63.22% | 145,625 0.24% of shares | low |
| Feb 4, 2026 | Stansky Michael P Director | Grant | Director Stock Option (right to buy) | — | +93K | 92,537 0.15% of shares | low |